{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:01:34Z","timestamp":1788886894335,"version":"build-2803163510"},"reference-count":83,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018625","name":"Science and Technology Innovation Plan Of Shanghai Science and Technology Commission","doi-asserted-by":"publisher","award":["21S11902400"],"award-info":[{"award-number":["21S11902400"]}],"id":[{"id":"10.13039\/501100018625","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473835"],"award-info":[{"award-number":["82473835"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["42076094"],"award-info":[{"award-number":["42076094"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773627"],"award-info":[{"award-number":["81773627"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.lfs.2025.123556","type":"journal-article","created":{"date-parts":[[2025,3,9]],"date-time":"2025-03-09T22:24:31Z","timestamp":1741559071000},"page":"123556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["To explore the influencing factors of clinical failure of anti-tumor necrosis factor-\u03b1 (TNF-\u03b1) therapy in sepsis"],"prefix":"10.1016","volume":"369","author":[{"given":"Yonghong","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoran","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2025.123556_bb0005","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for Sepsis and septic shock (Sepsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"Jama"},{"key":"10.1016\/j.lfs.2025.123556_bb0010","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the global burden of disease study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2025.123556_bb0015","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1097\/CM9.0000000000000392","article-title":"Epidemiology of Sepsis-3 in a sub-district of Beijing: secondary analysis of a population-based database","volume":"132","author":"Tian","year":"2019","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.lfs.2025.123556_bb0020","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jconrel.2021.06.022","article-title":"Down-regulation of TNF-\u03b1 via macrophage-targeted RNAi system for the treatment of acute inflammatory sepsis","volume":"336","author":"Lee","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.lfs.2025.123556_bb0025","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1097\/CCM.0000000000000043","article-title":"Evaluating the efficacy and safety of two doses of the polyclonal anti-tumor necrosis factor-\u03b1 fragment antibody AZD9773 in adult patients with severe sepsis and\/or septic shock: randomized, double-blind, placebo-controlled phase IIb study*","volume":"42","author":"Bernard","year":"2014","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.lfs.2025.123556_bb0030","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1097\/00003246-200107001-00037","article-title":"Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned","volume":"29","author":"Reinhart","year":"2001","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.lfs.2025.123556_bb0035","doi-asserted-by":"crossref","unstructured":"C.J. Fisher, Jr., J.M. Agosti, S.M. Opal, S.F. Lowry, R.A. Balk, J.C. Sadoff, E. Abraham, R.M. Schein, E. Benjamin, Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. The Soluble TNF Receptor Sepsis Study Group, N Engl J Med. 334 (1996) 1697\u20131702. doi:https:\/\/doi.org\/10.1056\/NEJM199606273342603.","DOI":"10.1056\/NEJM199606273342603"},{"key":"10.1016\/j.lfs.2025.123556_bb0040","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ccc.2017.08.003","article-title":"Mechanisms of organ dysfunction in Sepsis","volume":"34","author":"Pool","year":"2018","journal-title":"Crit. Care Clin."},{"key":"10.1016\/j.lfs.2025.123556_bb0045","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.3389\/fimmu.2018.01133","article-title":"Pro-inflammatory Th1 and Th17 cells are suppressed during human experimental Endotoxemia whereas anti-inflammatory IL-10 producing T-cells are unaffected","volume":"9","author":"Brinkhoff","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2025.123556_bb0050","first-page":"7223","article-title":"Prognostic value of circulating lymphocyte B and plasma immunoglobulin M on septic shock and sepsis: a systematic review and meta-analysis","volume":"11","author":"Tian","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.lfs.2025.123556_bb0055","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s10753-010-9253-9","article-title":"Acute lung inflammation in Klebsiella pneumoniae B5055-induced pneumonia and sepsis in BALB\/c mice: a comparative study","volume":"34","author":"Kumar","year":"2011","journal-title":"Inflammation"},{"key":"10.1016\/j.lfs.2025.123556_bb0060","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00281-017-0639-8","article-title":"Cytokine storm and sepsis disease pathogenesis","volume":"39","author":"Chousterman","year":"2017","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.lfs.2025.123556_bb0065","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cyto.2012.11.016","article-title":"Tumor necrosis factor gene polymorphism results in high TNF level in sepsis and septic shock","volume":"61","author":"Kothari","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.lfs.2025.123556_bb0070","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1038\/nrd3794","article-title":"Targeting IL-17 and TH17 cells in chronic inflammation","volume":"11","author":"Miossec","year":"2012","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.lfs.2025.123556_bb0075","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aba9600","article-title":"A novel TNFR2 agonist antibody expands highly potent regulatory T cells","volume":"13","author":"Torrey","year":"2020","journal-title":"Sci. Signal."},{"key":"10.1016\/j.lfs.2025.123556_bb0080","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2249.2007.03356.x","article-title":"The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease","volume":"148","author":"Afzali","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.lfs.2025.123556_bb0085","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.injury.2013.03.015","article-title":"The imbalance between regulatory and IL-17-secreting CD4+T cells in multiple-trauma rat","volume":"44","author":"Dai","year":"2013","journal-title":"Injury"},{"key":"10.1016\/j.lfs.2025.123556_bb0090","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cyto.2016.09.010","article-title":"Coexistence of Th1\/Th2 and Th17\/Treg imbalances in patients with post traumatic sepsis","volume":"88","author":"Gupta","year":"2016","journal-title":"Cytokine"},{"key":"10.1016\/j.lfs.2025.123556_bb0095","article-title":"China critical care clinical trials, epidemiology and outcome of severe sepsis and septic shock in intensive care units in mainland China","volume":"9","author":"Zhou","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.lfs.2025.123556_bb0100","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.1097\/CCM.0000000000004155","article-title":"The epidemiology of Sepsis in Chinese ICUs: a National Cross-Sectional Survey","volume":"48","author":"Xie","year":"2020","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.lfs.2025.123556_bb0105","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00786-2018","article-title":"Neutrophils disturb pulmonary microcirculation in sepsis-induced acute lung injury","volume":"53","author":"Park","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.lfs.2025.123556_bb0110","doi-asserted-by":"crossref","unstructured":"L. Evans, A. Rhodes, W. Alhazzani, M. Antonelli, C.M. Coopersmith, C. French, F.R. Machado, L. McIntyre, M. Ostermann, H.C. Prescott, C. Schorr, S. Simpson, W.J. Wiersinga, F. Alshamsi, D.C. Angus, Y. Arabi, L. Azevedo, R. Beale, G. Beilman, E. Belley-Cote, L. Burry, M. Cecconi, J. Centofanti, A. Coz Yataco, J. De Waele, R.P. Dellinger, K. Doi, B. Du, E. Estenssoro, R. Ferrer, C. Gomersall, C. Hodgson, M. Hylander M\u00f8ller, T. Iwashyna, S. Jacob, R. Kleinpell, M. Klompas, Y. Koh, A. Kumar, A. Kwizera, S. Lobo, H. Masur, S. McGloughlin, S. Mehta, Y. Mehta, M. Mer, M. Nunnally, S. Oczkowski, T. Osborn, E. Papathanassoglou, A. Perner, M. Puskarich, J. Roberts, W. Schweickert, M. Seckel, J. Sevransky, C.L. Sprung, T. Welte, J. Zimmerman, M. Levy, Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021, Crit Care Med. 49 (2021) e1063-e1143. doi:https:\/\/doi.org\/10.1097\/ccm.0000000000005337.","DOI":"10.1097\/CCM.0000000000005337"},{"key":"10.1016\/j.lfs.2025.123556_bb0115","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1016\/j.immuni.2021.10.012","article-title":"The immunology of sepsis","volume":"54","author":"van der Poll","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.lfs.2025.123556_bb0120","doi-asserted-by":"crossref","unstructured":"L.L. Bastos, D. Mariano, R.P. Lemos, T.S. Bialves, C.J. Oliveira, R.C. de Melo-Minardi, The Role of Structural Bioinformatics in Understanding Tumor Necrosis Factor \u03b1-Interacting Protein Mechanisms in Chronic Inflammatory Diseases: A Review, in: Immuno, pp. 14\u201342. doi:https:\/\/doi.org\/10.3390\/immuno4010002.","DOI":"10.3390\/immuno4010002"},{"key":"10.1016\/j.lfs.2025.123556_bb0125","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S1359-6101(03)00022-4","article-title":"Biological functions of tumor necrosis factor cytokines and their receptors","volume":"14","author":"Pfeffer","year":"2003","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.lfs.2025.123556_bb0130","article-title":"Immunomodulatory effect and safety of TNF-\u03b1 RNAi mediated by oral yeast microcapsules in rheumatoid arthritis therapy","volume":"16","author":"Hu","year":"2022","journal-title":"Mater. Today Bio."},{"key":"10.1016\/j.lfs.2025.123556_bb0135","article-title":"TNF-\u03b1, a good or bad factor in hematological diseases?","volume":"1","author":"Tian","year":"2014","journal-title":"Stem Cell Investigation."},{"key":"10.1016\/j.lfs.2025.123556_bb0140","doi-asserted-by":"crossref","first-page":"1074863","DOI":"10.3389\/fimmu.2023.1074863","article-title":"The role of TNF-\u03b1 in the fate regulation and functional reprogramming of mesenchymal stem cells in an inflammatory microenvironment","volume":"14","author":"Li","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2025.123556_bb0145","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000342333","article-title":"Tumor necrosis factor receptors: biology and therapeutic potential in kidney diseases","volume":"36","author":"Speeckaert","year":"2012","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.lfs.2025.123556_bb0150","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.725473","article-title":"The TNF-\u03b1\/TNFR2 pathway: targeting a brake to release the anti-tumor immune response","volume":"9","author":"Moatti","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.lfs.2025.123556_bb0155","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nri3834","article-title":"Regulation of tumour necrosis factor signalling: live or let die","volume":"15","author":"Brenner","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.lfs.2025.123556_bb0160","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1038\/s41418-022-00938-9","article-title":"Caspase-8 auto-cleavage regulates programmed cell death and collaborates with RIPK3\/MLKL to prevent lymphopenia","volume":"29","author":"Li","year":"2022","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.lfs.2025.123556_bb0165","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.immuni.2020.04.002","article-title":"FADD and Caspase-8 regulate gut homeostasis and inflammation by controlling MLKL- and GSDMD-mediated death of intestinal epithelial cells","volume":"52","author":"Schwarzer","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.lfs.2025.123556_bb0170","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009032","article-title":"PARP inhibitors enhance antitumor immune responses by triggering pyroptosis via TNF-caspase 8-GSDMD\/E axis in ovarian cancer","volume":"12","author":"Xia","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.lfs.2025.123556_bb0175","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1053\/j.gastro.2015.06.004","article-title":"Tumor necrosis factor receptor 2 restricts the pathogenicity of CD8(+) T cells in mice with colitis","volume":"149","author":"Punit","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2025.123556_bb0180","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/s41419-018-1266-6","article-title":"Differential roles of TNF\u03b1-TNFR1 and TNF\u03b1-TNFR2 in the differentiation and function of CD4(+)Foxp3(+) induced Treg cells in vitro and in vivo periphery in autoimmune diseases","volume":"10","author":"Yang","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2025.123556_bb0185","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/978-981-15-6407-9_13","article-title":"TNF-TNFR2 signal plays a decisive role in the activation of CD4(+)Foxp3(+) regulatory T cells: implications in the treatment of autoimmune diseases and Cancer","volume":"1278","author":"Islam","year":"2021","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.lfs.2025.123556_bb0190","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cytogfr.2011.09.004","article-title":"Treatment of TNF mediated diseases by selective inhibition of soluble TNF or TNFR1","volume":"22","author":"Van Hauwermeiren","year":"2011","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.lfs.2025.123556_bb0195","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/j.chom.2024.08.007","article-title":"Paneth cell TNF signaling induces gut bacterial translocation and sepsis","volume":"32","author":"Wallaeys","year":"2024","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.lfs.2025.123556_bb0200","doi-asserted-by":"crossref","first-page":"16045","DOI":"10.1038\/nrdp.2016.45","article-title":"Sepsis and septic shock","volume":"2","author":"Hotchkiss","year":"2016","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"2023","key":"10.1016\/j.lfs.2025.123556_bb0205","article-title":"The pathogenesis and potential therapeutic targets in sepsis","volume":"4","author":"Zhang","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.lfs.2025.123556_bb0210","first-page":"629","article-title":"Organ dysfunction in Sepsis: An ominous trajectory from infection to death","volume":"92","author":"Caraballo","year":"2019","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.lfs.2025.123556_bb0215","doi-asserted-by":"crossref","unstructured":"Y.-y. Zhang, B.-t. Ning, Signaling pathways and intervention therapies in sepsis, Signal Transduct. Target. Ther. 6 (2021) 407. doi:https:\/\/doi.org\/10.1038\/s41392-021-00816-9.","DOI":"10.1038\/s41392-021-00816-9"},{"key":"10.1016\/j.lfs.2025.123556_bb0220","article-title":"Sepsis-pathophysiology and therapeutic concepts","volume":"8","author":"Jarczak","year":"2021","journal-title":"Front Med (Lausanne)."},{"key":"10.1016\/j.lfs.2025.123556_bb0225","doi-asserted-by":"crossref","first-page":"426","DOI":"10.4269\/ajtmh.2011.10-0310","article-title":"Tumor necrosis factor-\u03b1 and mortality in patients infected with Vibrio vulnificus","volume":"84","author":"Lee","year":"2011","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.lfs.2025.123556_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.156006","article-title":"Proinflammatory cytokines levels in sepsis and healthy volunteers, and tumor necrosis factor-alpha associated sepsis mortality: a systematic review and meta-analysis","volume":"158","author":"Gharamti","year":"2022","journal-title":"Cytokine"},{"key":"10.1016\/j.lfs.2025.123556_bb0235","doi-asserted-by":"crossref","unstructured":"C.M. Hendrickson, M.A. Matthay, Endothelial biomarkers in human sepsis: pathogenesis and prognosis for ARDS, Pulm Circ. 8 (2018) 2045894018769876.","DOI":"10.1177\/2045894018769876"},{"key":"10.1016\/j.lfs.2025.123556_bb0240","first-page":"129","article-title":"Lipopolysaccharide-induced tumor necrosis factor alpha production and not monocyte human leukocyte antigen-DR expression is correlated with survival in septic trauma patients","volume":"25","author":"Ploder","year":"2006","journal-title":"Shock"},{"key":"10.1016\/j.lfs.2025.123556_bb0245","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00134-010-2088-x","article-title":"Immunoparalysis and nosocomial infection in children with multiple organ dysfunction syndrome","volume":"37","author":"Hall","year":"2011","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.lfs.2025.123556_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.clim.2021.108714","article-title":"Differential response induced by LPS and MPLA in immunocompetent and septic individuals","volume":"226","author":"Albert Vega","year":"2021","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.lfs.2025.123556_bb0255","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41419-019-1808-6","article-title":"Inhibition of transmembrane TNF-\u03b1 shedding by a specific antibody protects against septic shock","volume":"10","author":"Li","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2025.123556_bb0260","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3389\/fcell.2020.00401","article-title":"Selective targeting of TNF receptors as a novel therapeutic approach","volume":"8","author":"Fischer","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.lfs.2025.123556_bb0265","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17111940","article-title":"Hydrostatin-TL1, an anti-inflammatory active peptide from the venom gland of Hydrophis cyanocinctus in the South China Sea","volume":"17","author":"Wang","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2025.123556_bb0270","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1517\/14656566.2013.777429","article-title":"Septic shock: new pharmacotherapy options or better trial design?","volume":"14","author":"Vincent","year":"2013","journal-title":"Expert. Opin. Pharmacother."},{"key":"10.1016\/j.lfs.2025.123556_bb0275","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1126\/science.adp1779","article-title":"Target-conditioned diffusion generates potent TNFR superfamily antagonists and agonists","volume":"386","author":"Gl\u00f6gl","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.lfs.2025.123556_bb0280","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/00003246-199605000-00003","article-title":"Assessment of the safety and efficacy of the monoclonal anti-tumor necrosis factor antibody-fragment, MAK 195F, in patients with sepsis and septic shock: a multicenter, randomized, placebo-controlled, dose-ranging study","volume":"24","author":"Reinhart","year":"1996","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.lfs.2025.123556_bb0285","doi-asserted-by":"crossref","unstructured":"C.J. Fisher, Jr., S.M. Opal, J.F. Dhainaut, S. Stephens, J.L. Zimmerman, P. Nightingale, S.J. Harris, R.M. Schein, E.A. Panacek, J.L. Vincent, et al., Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group, Crit Care Med. 21 (1993) 318\u2013327. doi:https:\/\/doi.org\/10.1097\/00003246-199303000-00006.","DOI":"10.1097\/00003246-199303000-00006"},{"key":"10.1016\/j.lfs.2025.123556_bb0290","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s10156-013-0612-y","article-title":"A phase II study of polyclonal anti-TNF-\u03b1 (AZD9773) in Japanese patients with severe sepsis and\/or septic shock","volume":"19","author":"Aikawa","year":"2013","journal-title":"J. Infect. Chemother."},{"key":"10.1016\/j.lfs.2025.123556_bb0295","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1007\/s00134-013-2967-z","article-title":"High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial","volume":"39","author":"Joannes-Boyau","year":"2013","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.lfs.2025.123556_bb0300","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00134-021-06501-3","article-title":"High dose coupled plasma filtration and adsorption in septic shock patients. Results of the COMPACT-2: a multicentre, adaptive, randomised clinical trial","volume":"47","author":"Garbero","year":"2021","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.lfs.2025.123556_bb0305","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003536","article-title":"Efficacy of coupled plasma filtration adsorption (CPFA) in patients with septic shock: a multicenter randomised controlled clinical trial","volume":"4","author":"Livigni","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.lfs.2025.123556_bb0310","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/1744-9987.14108","article-title":"Removal of inflammatory factors and prognosis of patients with septic shock complicated with acute kidney injury by hemodiafiltration combined with HA330-II hemoperfusion","volume":"28","author":"Zhou","year":"2024","journal-title":"Ther. Apher. Dial."},{"key":"10.1016\/j.lfs.2025.123556_bb0315","doi-asserted-by":"crossref","unstructured":"E. Abraham, R. Wunderink, H. Silverman, T.M. Perl, S. Nasraway, H. Levy, R. Bone, R.P. Wenzel, R. Balk, R. Allred, et al., Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group, Jama. 273 (1995) 934\u2013941.","DOI":"10.1001\/jama.1995.03520360048038"},{"key":"10.1016\/j.lfs.2025.123556_bb0320","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/ard.2010.135111","article-title":"The presence or absence of antibodies to infliximab or adalimumab determines the outcome of switching to etanercept","volume":"70","author":"Jamnitski","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.lfs.2025.123556_bb0325","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/apt.16333","article-title":"Early detection of anti-drug antibodies during initiation of anti-tumour necrosis factor therapy predicts treatment discontinuation in inflammatory bowel disease","volume":"53","author":"Tournier","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2025.123556_bb0330","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/ard.2005.045062","article-title":"Evidence for differential acquired drug resistance to anti-tumour necrosis factor agents in rheumatoid arthritis","volume":"65","author":"Finckh","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.lfs.2025.123556_bb0335","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.657768","article-title":"Emerging therapeutics for immune tolerance: Tolerogenic vaccines, T cell therapy, and IL-2 therapy","volume":"12","author":"Moorman","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2025.123556_bb0340","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3109\/09546634.2013.800184","article-title":"Clinical predictors of non-response to any tumor necrosis factor (TNF) blockers: a retrospective study","volume":"25","author":"Di Lernia","year":"2014","journal-title":"J. Dermatolog. Treat."},{"key":"10.1016\/j.lfs.2025.123556_bb0345","doi-asserted-by":"crossref","first-page":"H2281","DOI":"10.1152\/ajpheart.2001.280.5.H2281","article-title":"Effects of soluble TNF receptor treatment on lipopolysaccharide-induced myocardial cytokine expression","volume":"280","author":"Kadokami","year":"2001","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.lfs.2025.123556_bb0350","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1006\/jsre.1996.0312","article-title":"Dosage and timing of anti-TNF-alpha antibody treatment determine its effect of resistance to sepsis after injury","volume":"64","author":"O\u2019Riordain","year":"1996","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.lfs.2025.123556_bb0355","first-page":"2003","article-title":"Derivation","volume":"321","author":"Seymour","year":"2019","journal-title":"Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis, Jama."},{"key":"10.1016\/j.lfs.2025.123556_bb0360","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1097\/CCM.0000000000003260","article-title":"Presenting symptoms independently predict mortality in septic shock: importance of a previously unmeasured confounder","volume":"46","author":"Filbin","year":"2018","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.lfs.2025.123556_bb0365","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/CCM.0000000000003084","article-title":"Unsupervised analysis of transcriptomics in bacterial Sepsis across multiple datasets reveals three robust clusters","volume":"46","author":"Sweeney","year":"2018","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.lfs.2025.123556_bb0370","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4103\/1995-7645.289438","article-title":"Chinese expert consensus on early prevention and intervention of sepsis","volume":"13","author":"Wang","year":"2020","journal-title":"Asian Pac J Trop Med"},{"key":"10.1016\/j.lfs.2025.123556_bb0375","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12967-025-06122-0","article-title":"Exploring TNFR1: from discovery to targeted therapy development","volume":"23","author":"Li","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.lfs.2025.123556_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2022.106363","article-title":"Advancements, challenges and future perspectives on peptide-based drugs: focus on antimicrobial peptides","volume":"181","author":"Luo","year":"2023","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.lfs.2025.123556_bb0385","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41581-019-0199-3","article-title":"Prognostic and predictive enrichment in sepsis","volume":"16","author":"Stanski","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.lfs.2025.123556_bb0390","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.7150\/thno.72760","article-title":"Single-cell transcriptome profiling of the immune space-time landscape reveals dendritic cell regulatory program in polymicrobial sepsis","volume":"12","author":"Yao","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.lfs.2025.123556_bb0395","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/s41591-020-0752-4","article-title":"An immune-cell signature of bacterial sepsis","volume":"26","author":"Reyes","year":"2020","journal-title":"Nat. Med."},{"key":"10.1016\/j.lfs.2025.123556_bb0400","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1016\/j.cell.2019.10.019","article-title":"Genomes of subaerial Zygnematophyceae provide insights into land plant evolution","volume":"179","author":"Cheng","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.lfs.2025.123556_bb0405","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/nature09016","article-title":"The Ectocarpus genome and the independent evolution of multicellularity in brown algae","volume":"465","author":"Cock","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.lfs.2025.123556_bb0410","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/1755-0998.12988","article-title":"Chromosomal level reference genome of Tachypleus tridentatus provides insights into evolution and adaptation of horseshoe crabs","volume":"19","author":"Gong","year":"2019","journal-title":"Mol. Ecol. Resour."},{"key":"10.1016\/j.lfs.2025.123556_bb0415","doi-asserted-by":"crossref","first-page":"1242592","DOI":"10.1126\/science.1242592","article-title":"The genome of the ctenophore Mnemiopsis leidyi and its implications for cell type evolution","volume":"342","author":"Ryan","year":"2013","journal-title":"Science"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525001900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320525001900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T13:37:00Z","timestamp":1745501820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320525001900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":83,"alternative-id":["S0024320525001900"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123556","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"To explore the influencing factors of clinical failure of anti-tumor necrosis factor-\u03b1 (TNF-\u03b1) therapy in sepsis","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2025.123556","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123556"}}